CD274 and non-small cell lung carcinoma: The first‐line treatment strategies for NSCLC include the administration of programmed cell death‐1 (PD‐1) or programmed cell death‐ligand 1 (PD‐L1) inhibitors alone or in combination with platinum‐based chemotherapy [6, 7, 8, 9].